Medigus 

$2.36
39
+$0.18+8.28% Wednesday 22:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Aug 25
$3.94
Dec 22
$2.27
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

15NovExpected
Q3 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0.2
-0.13
-0.05
0.02
Expected EPS
0
Actual EPS
0

Financials

-10.68%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
91.86MRevenue
-9.82MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MDGS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical is a leading developer of robotic-assisted surgical systems, competing directly with Medigus's technology in the minimally invasive surgery market.
Medtronic
MDT
Mkt Cap116.33B
Medtronic offers a wide range of medical devices and technologies, including surgical solutions that compete with Medigus's offerings.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew specializes in medical equipment for surgery, directly competing with Medigus in the surgical devices market.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation produces medical devices used in interventional medical specialties, competing with Medigus in areas like endoscopy.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its medical devices segment, competes in the surgical and medical devices market, overlapping with Medigus's product lines.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation specializes in medical technologies, including surgical equipment, competing with Medigus in the medical devices sector.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. offers musculoskeletal healthcare products, competing with Medigus in the surgical devices and equipment market.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, while primarily a pharmaceutical company, has ventures in medical devices that could compete with Medigus's surgical technologies.
Baxter International
BAX
Mkt Cap9.49B
Baxter International develops, manufactures, and markets healthcare products, including surgical instruments and devices that compete with Medigus.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing with Medigus in the broader medical devices market.

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, visualization solutions, and resistant cameras; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
Show more...
CEO
Liron Carmel
Employees
77
Country
US
ISIN
US58471G3002
WKN
000A3D1UP

Listings

0 Comments

Share your thoughts

FAQ

What is Medigus stock price today?
The current price of MDGS is $2.36 USD — it has increased by +8.28% in the past 24 hours. Watch Medigus stock price performance more closely on the chart.
What is Medigus stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medigus stocks are traded under the ticker MDGS.
What were Medigus earnings last quarter?
MDGS earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Medigus revenue for the last year?
Medigus revenue for the last year amounts to 91.86M USD.
What is Medigus net income for the last year?
MDGS net income for the last year is -9.82M USD.
Does Medigus pay dividends?
Yes, MDGS dividends are paid en. The last dividend per share was 0.85 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Medigus have?
As of April 01, 2026, the company has 77 employees.
In which sector is Medigus located?
Medigus operates in the Manufacturing sector.
When did Medigus complete a stock split?
The last stock split for Medigus was on November 14, 2022 with a ratio of 1:15.
Where is Medigus headquartered?
Medigus is headquartered in Pob 3030, US.